PAR 4.08% 25.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-67

  1. 569 Posts.
    lightbulb Created with Sketch. 239
    Hey Denial, yes I heard it, but I have heard very similar quotes before - "term sheets are ready & going back and forth".

    Some choose to believe, I do not.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.